Neurophos Raises $7.2 Million Round to Create Super-fast, Energy-Efficient Metamaterial-Based Optical AI Chips for Data Centers
Neurophos is a metamaterial-based start-up developing optical computing chips. It was founded by PhD graduate Patrick Bowen and spun out of the lab of Professor David Smith (ECE, Pratt).
Ten63 Therapeutics Announces Multi-Target Drug Discovery Collaboration with Boehringer Ingelheim
Ten63 is a Duke University start-up and DCP portfolio company out of the lab of Professor Bruce Donald (Computer Science, Trinity).
Tune Therapeutics Presents First Data Supporting TUNE-401: a First-in-Class Epigenetic Silencer for Hepatitis B
Tune Therapeutics is a Duke start-up and DCP portfolio company developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).
Invented at Duke 2023 – Engineering highlights
The Pratt School of Engineering was a big participant in the 5th Annual Invented at Duke, with multiple inventors and resources. Watch the video here.
Invented at Duke 2023 showcases a bustling innovation ecosystem
Featuring inventor booths, innovation resources, and strong support in speeches from leaders, Invented at Duke 2023 caps a big year for OTC.
Can nanosensor technology and stem cell transplants revolutionise type 1 diabetes treatment? – Diabetes Voice
Minutia is a next generation cell therapy start-up co-founded by cell sensing luminary Professor Tuan Vo-Dinh (BME, Pratt).
Duke Spinoff Tyrata Acquired by Bridgestone
A tire tech startup hatched at Duke Engineering has fully fledged the nest to become part of one of the world’s largest tire manufacturers.
Sparta Biomedical Recognized with the MedTech Innovator Execution Award and the AdvaMed Accel Virginia Shimer Rybski Memorial Award
Duke start-up Sparta Biomedical wins industry awards from both AdvaMed and MedTech Innovator.
Gilhuly Accelerator Fund Invests Over $1M in Duke Inventor Projects in its Inaugural Year
The Duke community, led by Trustee Ned Gilhuly, is supporting Duke inventors with its newest translational fund dedicated to accelerating the development of early-stage technologies with high commercial potential.